Simeprevir, sofosbuvir and ribavirin to treat genotype 1 patients with chronic hepatitis and psychiatric disorders for whom interferon therapy is contraindicated.

Trial Profile

Simeprevir, sofosbuvir and ribavirin to treat genotype 1 patients with chronic hepatitis and psychiatric disorders for whom interferon therapy is contraindicated.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 20 May 2015

At a glance

  • Drugs Ribavirin (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary) ; Vitamin D
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms INSPIRE-C
  • Most Recent Events

    • 20 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top